Analytical Data
-
Gene name
TRIB1
- Application
-
Alternative Names
MLASA; tRNA pseudouridine(38-40) synthase; tRNA pseudouridine synthase A, mitochondrial; tRNA-uridine isomerase I
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y606
-
Expression Region
Met1~Asp427
-
Molecular Weight
51kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TRIB1, a member of the tribbles homolog family, has emerged as a crucial player in various biological processes, including cell signaling, metabolism, and immune responses. It functions as an atypical pseudokinase and is involved in the regulation of critical pathways such as the NF-κB signaling cascade. Dysregulation of TRIB1 has been implicated in several diseases, particularly in metabolic disorders and cancers, making it a potential therapeutic target. Research into TRIB1 recombinant proteins has gained traction, as these proteins allow for detailed studies of TRIB1’s structure-function relationships and its interactions with other cellular molecules. Using recombinant DNA technology, researchers can produce TRIB1 proteins in vitro for functional assays, structural analysis, and the identification of binding partners. Understanding the precise mechanisms by which TRIB1 influences cellular processes could provide insight into its role in disease and pave the way for novel therapeutic strategies. Thus, the study of TRIB1 recombinant proteins is pivotal for unraveling the complexities of this vital protein's function and its contributions to human health and disease.
